Topic: rare diseases
-
AI Outperforms Doctors in Rare Disease Diagnosis
DeepRare, an AI system from Shanghai Jiao Tong University, outperformed experienced physicians in diagnosing rare diseases, achieving higher accuracy and offering hope for faster diagnosis. The system is transparent and trusted by doctors, using a logical, step-by-step reasoning process that inte...
Read More » -
AI's Role in Solving Rare Disease Treatment Shortages
Artificial intelligence is transforming drug discovery by enabling small teams to tackle previously neglected diseases, acting as a productivity multiplier to overcome talent shortages and resource constraints. AI is being applied to both drug design and targeted gene therapy delivery, with compa...
Read More » -
Crispr Pioneer Launches Startup for Custom Gene-Editing Therapies
Aurora Therapeutics, co-founded by CRISPR pioneer Jennifer Doudna, aims to scale personalized gene-editing treatments for rare diseases using a novel FDA regulatory pathway that allows approval based on data from a small number of patients. The company's initial focus is on phenylketonuria (PKU),...
Read More » -
The Future of Gene Editing: Curing Disease Without Limits
David Liu announced a new disease-agnostic gene-editing strategy that could treat multiple unrelated illnesses using a unified molecular framework. Current gene therapies are expensive and tailored to rare conditions, whereas Liu's approach aims to be a universal, scalable platform for broader ap...
Read More »